An edition of Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages (2013)

Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages

hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012

By United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health